Pharmaceutical Grade Silica: Specifications, USP/EP Standards and Uses as an Excipient

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Synthetic Amorphous Silica (SAS)? Types, Safety and Regulatory Status
  • Keywords: pharmaceutical grade silica
  • Published: 2026-11-20 07:42:18
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Mesoporous carriers also offer an attractive alternative in the oral therapy of macromolecules rather than the more complicated parenteral administration. Peptides and proteins may denature in the greatly acidic environment of the stomach, lose their structure and function [ 1, 13 ], while the proteases in the digestive system break down the protein chains, making the molecule useless and the therapy ineffective [ 1, 13, 91 ]. Additionally, poor permeation through the epithelium is another hindering component during the oral administration of macromolecules [ 1, 13 ]. The macromolecule locked inside the pores stays protected against enzymatic or chemical degradation, and its permeation through the epithelium can also be improved [ 1, 13, 91 ]. It is also true that smaller pores deliver better protection for macromolecules against degradation [ 1 ]. Mesoporous silica nanocarriers have extra intriguing advantages because of their special properties that make them outstanding over other carriers and therefore provide a popular alternative in formulating macromolecules [ 1, 13 ].

Quartz for Engineered Stone: Purity, Whiteness and Safety Requirements

5N Quartz Sand: Purity Specifications, Key Impurities and High-Tech Applications
Silicon Oxide Anode (SiOx): How It Works and Its Advantages for Lithium-Ion Batteries
On The Bright Side
What Is Modified Silica? Surface Modification Methods and Performance Benefits
How to Disperse Fumed Silica: Methods, Equipment and Common Mistakes

Colloidal Silica Slurry: Specifications and Uses in CMP and Precision Polishing

What is silica (SiO₂)?

electronic grade silica In recent years, mesoporous silica nanocarriers have attracted great interest in pharmaceutical science because of their advantageous properties. Straightforward synthesis, low production cost, and tunable physicochemical properties characterize them. Their behavior in the human body, including targeting possibilities, can be influenced by particle size, particle morphology, pore size, internal structure, and surface chemistry. By modifying the surface functional groups and the surface charge, targeted therapy is achievable in several medical conditions. A wide range of drug loading methods is available (whether solvent-based or solvent-free techniques), so the most appropriate method can be selected, and higher drug concentration can be encapsulated, enhancing loading efficiency. Nevertheless, their formulation for different delivery routes, such as dermal, pulmonary, or the most favorable oral administration, is very difficult due to their large particular surface, adhesivity, and low density, which leads to poor powder flow properties, posing a huge difficulty in the manufacturing and formulation of solid dosage forms. Agglomeration of the particles by granulation or pelletization is a brilliant remedy for enhancing flowability. Concluding this, the granulation process of mesoporous silica has to be investigated and optimized to sustain the initially high porosity and high particular surface area of the material.

What is the difference between fumed silica and precipitated silica?

silica melting point Mesoporous silica nanocarriers (MSNs) have emerged as considerable candidates in the pharmaceutical industry for drug delivery systems, suitable for a wide range of drugs. Absorbing the active pharmaceutical ingredients (APIs) into the pores can be handy in several ways. The narrow pores may stabilize the APIs in an amorphous state, thereby boosting its aqueous solubility and supplying protection for the encapsulated drug against various takes into consideration the human body, such as enzymatic or chemical degradation, which boosts the bioavailability of the product. Beside the overview of their main traits, the present review focuses on the recent findings on MSNs form therapeutic and drug formulation perspective, such as functionalization possibilities, as the size and surface of the particles influence the interactions with the cell membrane; therefore, the epithelial permeability of and release rate from the carrier, and may offer even targeted delivery in an organ-, tissue- or cell-specific manner, improving the therapy, also steering clear of drug-related side impacts.

What drives silica raw material prices?

silica vs silicon

Cite this article: Silica Raw Materials News. "U.S. Silica: Company Overview, Products and Markets Served ." Published 2026-11-20 07:42:18. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.